Immunosuppressive treatment for proliferative lupus nephritis

BACKGROUND: Cyclophosphamide, in combination with corticosteroids, has been first‐line treatment for inducing disease remission for proliferative lupus nephritis, reducing death at five years from over 50% in the 1950s and 1960s to less than 10% in recent years. Several treatment strategies designed...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cochrane Database Syst Rev
Glavni autori: Tunnicliffe, David J, Palmer, Suetonia C, Henderson, Lorna, Masson, Philip, Craig, Jonathan C, Tong, Allison, Singh‐Grewal, Davinder, Flanc, Robert S, Roberts, Matthew A, Webster, Angela C, Strippoli, Giovanni FM
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons, Ltd 2018
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6513226/
https://ncbi.nlm.nih.gov/pubmed/29957821
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD002922.pub4
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items